Loading news...
Dentsply Sirona Inc. (XRAY) is the world's largest supplier of dental products and technologies, operating in over 100 countries. XRAY's business is segmented into Connected Technology Solutions, Orthodontic and Implant Solutions, Essential Dental Solutions, and the smaller Wellspect Healthcare. Despite performance issues, its investment grade bonds offering 8.5% current yield remain appealing.
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Dentsply Sirona Inc. (NASDAQ: XRAY) breached their fiduciary duties to shareholders. If you currently own Dentsply stock and are a long-term shareholder, you may be able to seek corporate governance reforms, the return of funds back to the company, a court-approved financial incentive award, or other relief and benefits. Please click here to learn more about your.
CHARLOTTE, N.C., Jan. 14, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY), the world's largest diversified manufacturer of professional dental products and technologies, and Patterson Dental Holdings (“Patterson Dental”), a leading supplier of products and services to the dental and animal health end markets, today announced the renewal of their U.S. dental technology distribution agreement.
DENTSPLY SIRONA Inc. (XRAY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Benco Dental will offer Dentsply Sirona's full portfolio of dental technology solutions, in addition to the consumables portfolio. Expanding the decades-long relationship reflects a shared vision to advance connected dentistry by facilitating access to an integrated ecosystem that connects devices, software, and people—from scanning to designing and manufacturing—for greater efficiency and better patient outcomes.
CHARLOTTE, N.C., Jan. 13, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced the appointment of Donald (Don) Zurbay to its Board of Directors (the “Board”), effective January 10, 2026.
CHARLOTTE, N.C., Jan. 12, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY), the world's largest diversified manufacturer of professional dental products and technologies, today announced the appointment of Mark R.
Commonwealth Equity Services LLC lifted its position in DENTSPLY SIRONA Inc. (NASDAQ: XRAY) by 38.4% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 804,934 shares of the medical instruments supplier's stock after purchasing an additional 223,339 shares during the
CHARLOTTE, N.C., Jan. 06, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will participate in the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 13, 2026, at 3:00 p.m. PT (6:00 p.m. ET). During the presentation, Dan Scavilla, President and CEO of Dentsply Sirona, will provide an update on the Company's differentiated Connected Dentistry portfolio, dental market trends and the Company's progress against its return-to-growth strategy.
Shares of DENTSPLY SIRONA Inc. (NASDAQ: XRAY - Get Free Report) have been assigned an average recommendation of "Reduce" from the fifteen brokerages that are covering the stock, Marketbeat.com reports. Three investment analysts have rated the stock with a sell recommendation, ten have issued a hold recommendation and two have given a buy recommendation to the
DENTSPLY SIRONA Inc. (NASDAQ: XRAY - Get Free Report) has received a consensus recommendation of "Reduce" from the fifteen analysts that are presently covering the company, Marketbeat.com reports. Three research analysts have rated the stock with a sell recommendation, ten have issued a hold recommendation and two have given a buy recommendation to the company. The
CHARLOTTE, N.C., Dec. 15, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the “Company”) (Nasdaq: XRAY) announced that its Board of Directors declared a quarterly cash dividend of $0.16 per share of common stock, an indicated annual rate of $0.64 per share.
Brandes Investment Partners LP grew its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ: XRAY) by 257.2% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 376,662 shares of the medical instruments supplier's stock after acquiring an additional 271,221
Shares of DENTSPLY SIRONA Inc. (NASDAQ: XRAY - Get Free Report) have been assigned an average rating of "Hold" from the fourteen ratings firms that are currently covering the firm, Marketbeat reports. Two equities research analysts have rated the stock with a sell recommendation, ten have issued a hold recommendation and two have given a buy
Creative Planning grew its stake in DENTSPLY SIRONA Inc. (NASDAQ: XRAY) by 311.9% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 113,875 shares of the medical instruments supplier's stock after purchasing an additional 86,227 shares during the period. Creative
Bristol Myers Squibb has a high dividend yield, is very cheap, and may have better growth prospects than it might seem at first glance. Pfizer now has a 7% yield, and may have found a solution to its patent cliff issue.
Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:
Bank of Montreal Can grew its position in DENTSPLY SIRONA Inc. (NASDAQ: XRAY) by 8.2% in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 352,524 shares of the medical instruments supplier's stock after purchasing an additional 26,610 shares during the
Brickwood added 1,496,935 shares of XRAY, raising position value by $19.03 million. The transaction represented 15.2% of Brickwood's 13F reportable assets under management.
Explore how Dentsply's (XRAY) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.